A Randomized Control Study on the Procedure for Switching Epoetin Beta (EPO) to Epoetin Beta Pegol (CERA) in the Treatment of Renal Anemia in Maintenance Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|38|3-4|174-179

ISSN： 0253-5068

Source： Blood Purification, Vol.38, Iss.3-4, 2014-12, pp. : 174-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Stress in Renal Anemia of Hemodialysis Patients Is Mitigated by Epoetin Treatment

By  

Kidney and Blood Pressure Research, Vol. 28, Iss. 5-6, 2006-03 ,pp. : 295-301

Karger

Access to resources Recommend Favorite

Tolerability and Efficacy of Multidose Epoetin Beta (Reco-Pen®) for Subcutaneous Administration in Patients with Anemia due to Renal Failure

By  

Kidney and Blood Pressure Research, Vol. 26, Iss. 3, 2003-07 ,pp. : 192-198

Karger

Access to resources Recommend Favorite

Effects of Treatment with Epoetin Beta on Outcomes in Patients with Anaemia and Chronic Heart Failure

By  

Kidney and Blood Pressure Research, Vol. 28, Iss. 1, 2005-01 ,pp. : 41-47

Karger

Access to resources Recommend Favorite

Cardiovascular Mortality in Haemodialysis Patients Treated with Epoetin Beta – A Retrospective Study

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 455-462

Karger

Access to resources Recommend Favorite

Effects of Optimized Heart Failure Therapy and Anemia Correction with Epoetin β on Left Ventricular Mass in Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 25, Iss. 3, 2005-07 ,pp. : 211-220

Karger

Access to resources Recommend Favorite